Palomino Laboratories Inc.
PALX
$15.32
-$0.08-0.52%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.18M | -3.42M | -3.16M | -2.43M | -612.10K |
| Total Depreciation and Amortization | 15.30K | 2.80K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.75M | 1.08M | 1.90M | 1.89M | 420.90K |
| Change in Net Operating Assets | -32.40K | -64.50K | -24.80K | 143.00K | 104.60K |
| Cash from Operations | -3.44M | -2.40M | -1.29M | -396.50K | -86.60K |
| Capital Expenditure | -1.26M | -318.30K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.26M | -318.30K | -- | -- | -- |
| Total Debt Issued | 0.00 | 1.70M | 1.70M | 1.70M | 1.70M |
| Total Debt Repaid | -352.40K | -352.40K | -352.40K | -- | -- |
| Issuance of Common Stock | 24.58M | 9.76M | 9.76M | 8.02M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.80M | -1.86M | -1.83M | -1.56M | -25.00K |
| Cash from Financing | 22.42M | 9.24M | 9.27M | 8.15M | 1.67M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.72M | 6.52M | 7.99M | 7.76M | 1.58M |